StockComparison Logo
vs

MXCT vs CGTX

Comparison between MaxCyte Inc (MXCT, Company) and Cognition Therapeutics Inc (CGTX, Company).

Both MXCT and CGTX are from the Healthcare sector.

5-Year PerformanceMXCT has outperformed CGTX, delivering a return of -27.4% compared to -35.0%

MXCT vs CGTX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
MXCT
$130M
CGTX
$130M
Max Drawdown
Winner
MXCT
96.07%
CGTX
98.16%
Sharpe Ratio
MXCT
-0.47
Winner
CGTX
1.93
5Y Beta
Winner
MXCT
1.29
CGTX
1.84
Industry
MXCT
Medical Devices
CGTX
Biotechnology
P/E Ratio
Winner
MXCT
-3.30
CGTX
-3.05
5Y EPS CAGR
MXCT
12.02%
CGTX
N/A
Debt to Equity
MXCT
0.00%
CGTX
0.00%
Free Cash Flow Yield
MXCT
-22.65%
Winner
CGTX
-15.63%
P/S Ratio
MXCT
4.01
CGTX
N/A
P/B Ratio
Winner
MXCT
0.76
CGTX
4.31

MXCT vs CGTX - Historical Returns

Returns include dividend reinvestment.

1M
MXCT
+13.46%
Winner
CGTX
+33.33%
3M
Winner
MXCT
+55.90%
CGTX
+48.67%
6M
MXCT
-27.61%
Winner
CGTX
+5.66%
1Y
MXCT
-45.62%
Winner
CGTX
+547.40%
5Y(CAGR)
Winner
MXCT
-27.40%
CGTX
-35.03%
Max(CAGR)
Winner
MXCT
-4.48%
CGTX
-35.03%

MXCT vs CGTX - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

YearMXCTCGTX
2026-23.87%+14.29%
2025-62.65%+86.70%
2024-16.80%-63.85%
2023-8.20%-9.76%
2022-49.63%-66.40%
2021+525.15%-50.51%
2020+0.00%N/A
2019+2.31%N/A

MXCT vs CGTX Drawdown Comparison

The maximum drawdown for MXCT was -96.07%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for CGTX was -98.16%, occurring on May 30, 2025. This drawdown has not yet recovered.

The current MXCT drawdown is -93.14%. The current CGTX drawdown is -87.06%.

RankMXCTCGTX
#1-96.07%
Sep 3, 2021 - Mar 30, 2026
-98.16%
Nov 9, 2021 - May 30, 2025
#2-37.58%
Jan 22, 2021 - Jul 30, 2021
-6.81%
Oct 8, 2021 - Nov 9, 2021
#3-19.65%
Jul 30, 2021 - Sep 3, 2021
N/A

Correlation

Correlation between MXCT and CGTX is 0.76 which considered as a strong positive correlation - the stocks tend to move together.

0.76
-101

Select Stocks to Compare